Skip to main content
S&P 5007,597.54-0.78%DOW52,322.32-0.48%NASDAQ26,045.26-1.09%BTC$78,412.00+1.57%ETH$2,503.45+0.44%GOLD$4,310.10-2.24%OIL$104.21+4.16%
Smart Investors Daily
PE

NASDAQ · PETV

PetVivo Holdings, Inc.

Healthcare · Medical - Devices

$0.68

Up+$0.00 (+0.00%)

Updated Sep 14, 2026, 2:43 PM

SID Score

3.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
25.07M
P/E ratio
-3.05
Dividend yield
0.00%
52-week range
$0.45 – $1.69
Volume
6.84K
Avg. volume
29.13K

Price performance

PETV price history

1M range · 0 trading sessions · Daily adjusted prices

PETV does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest PETV news

The latest Smart Investors Daily articles mentioning PETV.

Stock researchCompany · Overview

PETV research

Overview

Company profile and research snapshot.

Company profile

PETVIVO HOLDINGS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
PETV recent ratings
DateFirmRatingTarget
Oct 12, 2021ThinkEquityBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 20, 2026

PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION

New Human Health Subsidiary to Advance Development of Innovative Biomaterial Technologies and Potential New Products for Human and Animal Health MINNEAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) ("PetVivo" or the “Company”), an emerging biomedical device company focused on the commercialization and development of innovative medical devices and therapeutics, announced today that its subsidiary, Cosmeta Corp., has changed its name to Somatrix Technologies, Inc. ("

Yahoo · Aug 14, 2026

PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported financial and operational results for the first quarter of its fiscal year ended June 30, 2026. PetVivo will hold a conference call today at 5:00 p.m. Eastern time to discuss the res

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By